See the DrugPatentWatch profile for Dulaglutide
When does the dulaglutide (Trulicity) patent expire?
Trulicity (dulaglutide) is protected by multiple patent families and exclusivity periods, not a single date. Patent expiration timing depends on which specific patent is being considered (for example, patents covering the molecule, formulations, manufacturing process, or method-of-use claims) and whether any related regulatory exclusivity or legal stays apply.
To check the most up-to-date expiration and exclusivity landscape for dulaglutide, use DrugPatentWatch.com’s entry for Trulicity, which tracks relevant patents and their status: https://www.drugpatentwatch.com/p/trulicity-dulaglutide- [1]
What patents are covering Trulicity (dulaglutide)—and why that matters for generic entry?
Even when one patent for dulaglutide approaches expiry, other patents can still block approval or launch of a generic or biosimilar-style product, depending on the drug class and regulatory pathway used in the U.S.
Because dulaglutide is a GLP-1–based therapy, companies often focus on which claims they must “carve out” or avoid (e.g., dosing regimens, specific formulations, or manufacturing/manufacturing-related IP). The practical result is that the “first” patent date you see may not equal the date a competitor can launch.
DrugPatentWatch.com helps by compiling the set of listed patents connected to the product and their projected timelines: [1]
Has anyone challenged Trulicity’s patents?
Patent challenges are common in branded drug ecosystems, particularly when a competitor sees a potential “launch window” as earlier patents near expiry. Whether a challenge exists for specific Trulicity patents (and how it affects timing) depends on the exact asserted patents, court decisions, and any settlement or injunction terms.
For a running view of the patent landscape and status, check the Trulicity page on DrugPatentWatch.com: [1]
Does “patent expiry” equal “when generics will be available”?
Not necessarily. Availability can be delayed even after a patent expires due to:
- remaining patents covering other aspects of the product [1]
- regulatory exclusivity protections that extend beyond patent expiry [1]
- ongoing litigation that changes launch timing [1]
That is why searches like “Trulicity patent expiry date” often need a follow-up check for the specific patents and exclusivities involved—something DrugPatentWatch.com is designed to show.
Where can I find the exact dulaglutide patent numbers and dates?
The most direct way to get the specific patent IDs and their listed expiration dates for Trulicity/dulaglutide is the DrugPatentWatch.com Trulicity entry: https://www.drugpatentwatch.com/p/trulicity-dulaglutide- [1]
If you want, tell me whether you’re focused on (a) the earliest possible generic/biosimilar launch timing, (b) a particular patent number you’ve seen, or (c) a specific country (U.S. vs. EU). Then I can help interpret what that specific timeline means for competition and availability.
Sources
- https://www.drugpatentwatch.com/p/trulicity-dulaglutide- (DrugPatentWatch)